English
简体中文
Total: £ 56.28
Published Date: 2025-09-17 | Pages: 109 | Tables: 109 | Pharma & Healthcare
The global Probiotics for Infants and Women market size was US$ 634 million in 2024 and is forecast to a readjusted size of US$ 1115 million by 2031 with a CAGR of 8.5% during the forecast period 2025-2031.
By 2025, the evolving U.S. tariff policy is poised to inject considerable uncertainty into the global economic landscape. This report delves into the latest U.S. tariff measures and the corresponding policy responses across the globe, evaluating their impacts on Probiotics for Infants and Women market competitiveness, regional economic performance, and supply chain configurations.
In the 21st century, advances in technologies such as genetic sequencing have greatly accelerated gut microbiome research. As a result, our understanding of the health benefits and mechanisms of probiotics has become more comprehensive. Probiotics—live microorganisms that are generally recognized as beneficial to the host—have emerged as one of the most prominent applied categories in life sciences. For infants, probiotics help quickly establish and maintain a healthy gut microbiota. The two major families of probiotics are Lactobacillus and Bifidobacterium. While Lactobacillus functions similarly in both adults and infants, Bifidobacterium plays a particularly crucial role in early childhood. In women’s health, probiotic research primarily focuses on preventing and treating vaginitis and improving health during pregnancy and postpartum. Today, probiotics attract significant attention across ordinary foods, health supplements, and pharmaceuticals. This report focuses on probiotic powder ingredients for infants and women.
The market for probiotics tailored to infants and women is currently experiencing rapid growth. Rising health awareness and increasing consumer preference for natural and functional products are driving demand. In the maternal and infant product categories, probiotics have become a key functional ingredient, commonly added to infant formula, complementary foods, and probiotic drops. In women’s health, probiotics are increasingly used in dietary supplements aimed at improving reproductive health and regulating the gut microbiota. The probiotic raw powder segment, as a critical upstream component, has attracted strong attention from both domestic and international brands. Market players include traditional fermentation enterprises, biotech firms, and multinational health companies, contributing to an increasingly competitive landscape. With continued progress in basic research, accumulation of clinical evidence, and ongoing consumer education, the probiotics market for infants and women is expected to evolve toward greater specialization and precision. Future products will emphasize clearly defined probiotic strains supported by scientific validation. Personalized nutrition solutions and scenario-specific product designs will become major development directions. Regulatory frameworks will also become more rigorous, pushing the industry from a concept-driven to a standard- and evidence-based model. Moreover, innovative delivery systems (such as time-release capsules and smart microencapsulation) and combination formulations (such as synbiotics) will enhance product form and user experience. Key market drivers include the broader trend of upgraded health consumption, the rigid demand among specific groups such as infants and women, and the growing acceptance of microbiome science in both medical and wellness contexts. Ongoing innovation and sustained industry investment are also injecting momentum into the sector. However, the industry still faces significant challenges, such as inconsistent consumer understanding of probiotic benefits, lack of standardized strain efficacy data, variability in raw material quality, and issues with misleading marketing and regulatory gaps. These factors undermine product credibility and market penetration, posing obstacles to future growth.
The global Probiotics for Infants and Women market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
DuPont
Novonesis
Lallemand
BioGaia
Probi
Biosearch Life
Morinaga Milk Industry
Synbio Tech
Kerry Group
Nestle
Yakult
Sabinsa
Evivo
AB-Biotics
Bioflag Group
Beijing Scitop Bio-tech
Hebei Yiran Biological Technology
By Type: (Dominant Segment vs High-Margin Innovation)
Lactobacillus
Bifidobacterium
Others
By Application: (Core Demand Driver vs Emerging Opportunity)
Infant
Women
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., DuPont in Europe)
- Emerging Product Trends: Lactobacillus adoption vs. Bifidobacterium premiumization
- Demand-Side Dynamics: Infant growth in China vs. Women potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Japan
(Additional regions can be customized based on client needs.)
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Probiotics for Infants and Women market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Bifidobacterium in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Women in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
This is not just another market study. By fusing global trend analysis with hyper-local operational intelligence, we deliver:
- Risk-Controlled Market Entry: Navigate regulatory complexities in focus markets (e.g., China’s policies).
- Product Portfolio Optimization: Align offerings with regional preferences (e.g., Lactobacillus dominance in Europe vs. Bifidobacterium demand in MEA).
- Competitor Counterstrategies: Decode player tactics in fragmented vs. consolidated markets.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Market Overview
1.1 Probiotics for Infants and Women Product Scope
1.2 Probiotics for Infants and Women by Type
1.2.1 Global Probiotics for Infants and Women Sales by Type (2020 & 2024 & 2031)
1.2.2 Lactobacillus
1.2.3 Bifidobacterium
1.2.4 Others
1.3 Probiotics for Infants and Women by Application
1.3.1 Global Probiotics for Infants and Women Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Infant
1.3.3 Women
1.4 Global Probiotics for Infants and Women Market Estimates and Forecasts (2020-2031)
1.4.1 Global Probiotics for Infants and Women Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Probiotics for Infants and Women Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Probiotics for Infants and Women Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Probiotics for Infants and Women Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Probiotics for Infants and Women Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Probiotics for Infants and Women Sales Market Share by Region (2020-2025)
2.2.2 Global Probiotics for Infants and Women Revenue Market Share by Region (2020-2025)
2.3 Global Probiotics for Infants and Women Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Probiotics for Infants and Women Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Probiotics for Infants and Women Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Probiotics for Infants and Women Market Size and Prospective (2020-2031)
2.4.2 Europe Probiotics for Infants and Women Market Size and Prospective (2020-2031)
2.4.3 China Probiotics for Infants and Women Market Size and Prospective (2020-2031)
2.4.4 Japan Probiotics for Infants and Women Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Probiotics for Infants and Women Historic Market Review by Type (2020-2025)
3.1.1 Global Probiotics for Infants and Women Sales by Type (2020-2025)
3.1.2 Global Probiotics for Infants and Women Revenue by Type (2020-2025)
3.1.3 Global Probiotics for Infants and Women Price by Type (2020-2025)
3.2 Global Probiotics for Infants and Women Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Probiotics for Infants and Women Sales Forecast by Type (2026-2031)
3.2.2 Global Probiotics for Infants and Women Revenue Forecast by Type (2026-2031)
3.2.3 Global Probiotics for Infants and Women Price Forecast by Type (2026-2031)
3.3 Different Types Probiotics for Infants and Women Representative Players
4 Global Market Size by Application
4.1 Global Probiotics for Infants and Women Historic Market Review by Application (2020-2025)
4.1.1 Global Probiotics for Infants and Women Sales by Application (2020-2025)
4.1.2 Global Probiotics for Infants and Women Revenue by Application (2020-2025)
4.1.3 Global Probiotics for Infants and Women Price by Application (2020-2025)
4.2 Global Probiotics for Infants and Women Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Probiotics for Infants and Women Sales Forecast by Application (2026-2031)
4.2.2 Global Probiotics for Infants and Women Revenue Forecast by Application (2026-2031)
4.2.3 Global Probiotics for Infants and Women Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Probiotics for Infants and Women Application
5 Competition Landscape by Players
5.1 Global Probiotics for Infants and Women Sales by Players (2020-2025)
5.2 Global Top Probiotics for Infants and Women Players by Revenue (2020-2025)
5.3 Global Probiotics for Infants and Women Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Probiotics for Infants and Women as of 2024)
5.4 Global Probiotics for Infants and Women Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Probiotics for Infants and Women, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Probiotics for Infants and Women, Product Type & Application
5.7 Global Key Manufacturers of Probiotics for Infants and Women, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Probiotics for Infants and Women Sales by Company
6.1.1.1 North America Probiotics for Infants and Women Sales by Company (2020-2025)
6.1.1.2 North America Probiotics for Infants and Women Revenue by Company (2020-2025)
6.1.2 North America Probiotics for Infants and Women Sales Breakdown by Type (2020-2025)
6.1.3 North America Probiotics for Infants and Women Sales Breakdown by Application (2020-2025)
6.1.4 North America Probiotics for Infants and Women Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Probiotics for Infants and Women Sales by Company
6.2.1.1 Europe Probiotics for Infants and Women Sales by Company (2020-2025)
6.2.1.2 Europe Probiotics for Infants and Women Revenue by Company (2020-2025)
6.2.2 Europe Probiotics for Infants and Women Sales Breakdown by Type (2020-2025)
6.2.3 Europe Probiotics for Infants and Women Sales Breakdown by Application (2020-2025)
6.2.4 Europe Probiotics for Infants and Women Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Probiotics for Infants and Women Sales by Company
6.3.1.1 China Probiotics for Infants and Women Sales by Company (2020-2025)
6.3.1.2 China Probiotics for Infants and Women Revenue by Company (2020-2025)
6.3.2 China Probiotics for Infants and Women Sales Breakdown by Type (2020-2025)
6.3.3 China Probiotics for Infants and Women Sales Breakdown by Application (2020-2025)
6.3.4 China Probiotics for Infants and Women Major Customer
6.3.5 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Probiotics for Infants and Women Sales by Company
6.4.1.1 Japan Probiotics for Infants and Women Sales by Company (2020-2025)
6.4.1.2 Japan Probiotics for Infants and Women Revenue by Company (2020-2025)
6.4.2 Japan Probiotics for Infants and Women Sales Breakdown by Type (2020-2025)
6.4.3 Japan Probiotics for Infants and Women Sales Breakdown by Application (2020-2025)
6.4.4 Japan Probiotics for Infants and Women Major Customer
6.4.5 Japan Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 DuPont
7.1.1 DuPont Company Information
7.1.2 DuPont Business Overview
7.1.3 DuPont Probiotics for Infants and Women Sales, Revenue and Gross Margin (2020-2025)
7.1.4 DuPont Probiotics for Infants and Women Products Offered
7.1.5 DuPont Recent Development
7.2 Novonesis
7.2.1 Novonesis Company Information
7.2.2 Novonesis Business Overview
7.2.3 Novonesis Probiotics for Infants and Women Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Novonesis Probiotics for Infants and Women Products Offered
7.2.5 Novonesis Recent Development
7.3 Lallemand
7.3.1 Lallemand Company Information
7.3.2 Lallemand Business Overview
7.3.3 Lallemand Probiotics for Infants and Women Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Lallemand Probiotics for Infants and Women Products Offered
7.3.5 Lallemand Recent Development
7.4 BioGaia
7.4.1 BioGaia Company Information
7.4.2 BioGaia Business Overview
7.4.3 BioGaia Probiotics for Infants and Women Sales, Revenue and Gross Margin (2020-2025)
7.4.4 BioGaia Probiotics for Infants and Women Products Offered
7.4.5 BioGaia Recent Development
7.5 Probi
7.5.1 Probi Company Information
7.5.2 Probi Business Overview
7.5.3 Probi Probiotics for Infants and Women Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Probi Probiotics for Infants and Women Products Offered
7.5.5 Probi Recent Development
7.6 Biosearch Life
7.6.1 Biosearch Life Company Information
7.6.2 Biosearch Life Business Overview
7.6.3 Biosearch Life Probiotics for Infants and Women Sales, Revenue and Gross Margin (2020-2025)
7.6.4 Biosearch Life Probiotics for Infants and Women Products Offered
7.6.5 Biosearch Life Recent Development
7.7 Morinaga Milk Industry
7.7.1 Morinaga Milk Industry Company Information
7.7.2 Morinaga Milk Industry Business Overview
7.7.3 Morinaga Milk Industry Probiotics for Infants and Women Sales, Revenue and Gross Margin (2020-2025)
7.7.4 Morinaga Milk Industry Probiotics for Infants and Women Products Offered
7.7.5 Morinaga Milk Industry Recent Development
7.8 Synbio Tech
7.8.1 Synbio Tech Company Information
7.8.2 Synbio Tech Business Overview
7.8.3 Synbio Tech Probiotics for Infants and Women Sales, Revenue and Gross Margin (2020-2025)
7.8.4 Synbio Tech Probiotics for Infants and Women Products Offered
7.8.5 Synbio Tech Recent Development
7.9 Kerry Group
7.9.1 Kerry Group Company Information
7.9.2 Kerry Group Business Overview
7.9.3 Kerry Group Probiotics for Infants and Women Sales, Revenue and Gross Margin (2020-2025)
7.9.4 Kerry Group Probiotics for Infants and Women Products Offered
7.9.5 Kerry Group Recent Development
7.10 Nestle
7.10.1 Nestle Company Information
7.10.2 Nestle Business Overview
7.10.3 Nestle Probiotics for Infants and Women Sales, Revenue and Gross Margin (2020-2025)
7.10.4 Nestle Probiotics for Infants and Women Products Offered
7.10.5 Nestle Recent Development
7.11 Yakult
7.11.1 Yakult Company Information
7.11.2 Yakult Business Overview
7.11.3 Yakult Probiotics for Infants and Women Sales, Revenue and Gross Margin (2020-2025)
7.11.4 Yakult Probiotics for Infants and Women Products Offered
7.11.5 Yakult Recent Development
7.12 Sabinsa
7.12.1 Sabinsa Company Information
7.12.2 Sabinsa Business Overview
7.12.3 Sabinsa Probiotics for Infants and Women Sales, Revenue and Gross Margin (2020-2025)
7.12.4 Sabinsa Probiotics for Infants and Women Products Offered
7.12.5 Sabinsa Recent Development
7.13 Evivo
7.13.1 Evivo Company Information
7.13.2 Evivo Business Overview
7.13.3 Evivo Probiotics for Infants and Women Sales, Revenue and Gross Margin (2020-2025)
7.13.4 Evivo Probiotics for Infants and Women Products Offered
7.13.5 Evivo Recent Development
7.14 AB-Biotics
7.14.1 AB-Biotics Company Information
7.14.2 AB-Biotics Business Overview
7.14.3 AB-Biotics Probiotics for Infants and Women Sales, Revenue and Gross Margin (2020-2025)
7.14.4 AB-Biotics Probiotics for Infants and Women Products Offered
7.14.5 AB-Biotics Recent Development
7.15 Bioflag Group
7.15.1 Bioflag Group Company Information
7.15.2 Bioflag Group Business Overview
7.15.3 Bioflag Group Probiotics for Infants and Women Sales, Revenue and Gross Margin (2020-2025)
7.15.4 Bioflag Group Probiotics for Infants and Women Products Offered
7.15.5 Bioflag Group Recent Development
7.16 Beijing Scitop Bio-tech
7.16.1 Beijing Scitop Bio-tech Company Information
7.16.2 Beijing Scitop Bio-tech Business Overview
7.16.3 Beijing Scitop Bio-tech Probiotics for Infants and Women Sales, Revenue and Gross Margin (2020-2025)
7.16.4 Beijing Scitop Bio-tech Probiotics for Infants and Women Products Offered
7.16.5 Beijing Scitop Bio-tech Recent Development
7.17 Hebei Yiran Biological Technology
7.17.1 Hebei Yiran Biological Technology Company Information
7.17.2 Hebei Yiran Biological Technology Business Overview
7.17.3 Hebei Yiran Biological Technology Probiotics for Infants and Women Sales, Revenue and Gross Margin (2020-2025)
7.17.4 Hebei Yiran Biological Technology Probiotics for Infants and Women Products Offered
7.17.5 Hebei Yiran Biological Technology Recent Development
8 Probiotics for Infants and Women Manufacturing Cost Analysis
8.1 Probiotics for Infants and Women Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Probiotics for Infants and Women
8.4 Probiotics for Infants and Women Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Probiotics for Infants and Women Distributors List
9.3 Probiotics for Infants and Women Customers
10 Probiotics for Infants and Women Market Dynamics
10.1 Probiotics for Infants and Women Industry Trends
10.2 Probiotics for Infants and Women Market Drivers
10.3 Probiotics for Infants and Women Market Challenges
10.4 Probiotics for Infants and Women Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
List of Tables
Table 1. Global Probiotics for Infants and Women Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)
Table 2. Global Probiotics for Infants and Women Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)
Table 3. Global Market Probiotics for Infants and Women Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Probiotics for Infants and Women Sales (Tons) by Region (2020-2025)
Table 5. Global Probiotics for Infants and Women Sales Market Share by Region (2020-2025)
Table 6. Global Probiotics for Infants and Women Revenue (US$ Million) Market Share by Region (2020-2025)
Table 7. Global Probiotics for Infants and Women Revenue Share by Region (2020-2025)
Table 8. Global Probiotics for Infants and Women Sales (Tons) Forecast by Region (2026-2031)
Table 9. Global Probiotics for Infants and Women Sales Market Share Forecast by Region (2026-2031)
Table 10. Global Probiotics for Infants and Women Revenue (US$ Million) Forecast by Region (2026-2031)
Table 11. Global Probiotics for Infants and Women Revenue Share Forecast by Region (2026-2031)
Table 12. Global Probiotics for Infants and Women Sales by Type (Tons) & (2020-2025)
Table 13. Global Probiotics for Infants and Women Sales Share by Type (2020-2025)
Table 14. Global Probiotics for Infants and Women Revenue by Type (US$ Million) & (2020-2025)
Table 15. Global Probiotics for Infants and Women Price by Type (US$/kg) & (2020-2025)
Table 16. Global Probiotics for Infants and Women Sales by Type (Tons) & (2026-2031)
Table 17. Global Probiotics for Infants and Women Revenue by Type (US$ Million) & (2026-2031)
Table 18. Global Probiotics for Infants and Women Price by Type (US$/kg) & (2026-2031)
Table 19. Representative Players of Each Type
Table 20. Global Probiotics for Infants and Women Sales by Application (Tons) & (2020-2025)
Table 21. Global Probiotics for Infants and Women Sales Share by Application (2020-2025)
Table 22. Global Probiotics for Infants and Women Revenue by Application (US$ Million) & (2020-2025)
Table 23. Global Probiotics for Infants and Women Price by Application (US$/kg) & (2020-2025)
Table 24. Global Probiotics for Infants and Women Sales by Application (Tons) & (2026-2031)
Table 25. Global Probiotics for Infants and Women Revenue Market Share by Application (US$ Million) & (2026-2031)
Table 26. Global Probiotics for Infants and Women Price by Application (US$/kg) & (2026-2031)
Table 27. New Sources of Growth in Probiotics for Infants and Women Application
Table 28. Global Probiotics for Infants and Women Sales by Company (Tons) & (2020-2025)
Table 29. Global Probiotics for Infants and Women Sales Share by Company (2020-2025)
Table 30. Global Probiotics for Infants and Women Revenue by Company (US$ Million) & (2020-2025)
Table 31. Global Probiotics for Infants and Women Revenue Share by Company (2020-2025)
Table 32. Global Probiotics for Infants and Women by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Probiotics for Infants and Women as of 2024)
Table 33. Global Market Probiotics for Infants and Women Average Price by Company (US$/kg) & (2020-2025)
Table 34. Global Key Manufacturers of Probiotics for Infants and Women, Manufacturing Sites & Headquarters
Table 35. Global Key Manufacturers of Probiotics for Infants and Women, Product Type & Application
Table 36. Global Key Manufacturers of Probiotics for Infants and Women, Date of Enter into This Industry
Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 38. North America Probiotics for Infants and Women Sales by Company (2020-2025) & (Tons)
Table 39. North America Probiotics for Infants and Women Sales Market Share by Company (2020-2025)
Table 40. North America Probiotics for Infants and Women Revenue by Company (2020-2025) & (US$ Million)
Table 41. North America Probiotics for Infants and Women Revenue Market Share by Company (2020-2025)
Table 42. North America Probiotics for Infants and Women Sales by Type (2020-2025) & (Tons)
Table 43. North America Probiotics for Infants and Women Sales Market Share by Type (2020-2025)
Table 44. North America Probiotics for Infants and Women Sales by Application (2020-2025) & (Tons)
Table 45. North America Probiotics for Infants and Women Sales Market Share by Application (2020-2025)
Table 46. Europe Probiotics for Infants and Women Sales by Company (2020-2025) & (Tons)
Table 47. Europe Probiotics for Infants and Women Sales Market Share by Company (2020-2025)
Table 48. Europe Probiotics for Infants and Women Revenue by Company (2020-2025) & (US$ Million)
Table 49. Europe Probiotics for Infants and Women Revenue Market Share by Company (2020-2025)
Table 50. Europe Probiotics for Infants and Women Sales by Type (2020-2025) & (Tons)
Table 51. Europe Probiotics for Infants and Women Sales Market Share by Type (2020-2025)
Table 52. Europe Probiotics for Infants and Women Sales by Application (2020-2025) & (Tons)
Table 53. Europe Probiotics for Infants and Women Sales Market Share by Application (2020-2025)
Table 54. China Probiotics for Infants and Women Sales by Company (2020-2025) & (Tons)
Table 55. China Probiotics for Infants and Women Sales Market Share by Company (2020-2025)
Table 56. China Probiotics for Infants and Women Revenue by Company (2020-2025) & (US$ Million)
Table 57. China Probiotics for Infants and Women Revenue Market Share by Company (2020-2025)
Table 58. China Probiotics for Infants and Women Sales by Type (2020-2025) & (Tons)
Table 59. China Probiotics for Infants and Women Sales Market Share by Type (2020-2025)
Table 60. China Probiotics for Infants and Women Sales by Application (2020-2025) & (Tons)
Table 61. China Probiotics for Infants and Women Sales Market Share by Application (2020-2025)
Table 62. Japan Probiotics for Infants and Women Sales by Company (2020-2025) & (Tons)
Table 63. Japan Probiotics for Infants and Women Sales Market Share by Company (2020-2025)
Table 64. Japan Probiotics for Infants and Women Revenue by Company (2020-2025) & (US$ Million)
Table 65. Japan Probiotics for Infants and Women Revenue Market Share by Company (2020-2025)
Table 66. Japan Probiotics for Infants and Women Sales by Type (2020-2025) & (Tons)
Table 67. Japan Probiotics for Infants and Women Sales Market Share by Type (2020-2025)
Table 68. Japan Probiotics for Infants and Women Sales by Application (2020-2025) & (Tons)
Table 69. Japan Probiotics for Infants and Women Sales Market Share by Application (2020-2025)
Table 70. DuPont Company Information
Table 71. DuPont Description and Business Overview
Table 72. DuPont Probiotics for Infants and Women Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 73. DuPont Probiotics for Infants and Women Product
Table 74. DuPont Recent Development
Table 75. Novonesis Company Information
Table 76. Novonesis Description and Business Overview
Table 77. Novonesis Probiotics for Infants and Women Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 78. Novonesis Probiotics for Infants and Women Product
Table 79. Novonesis Recent Development
Table 80. Lallemand Company Information
Table 81. Lallemand Description and Business Overview
Table 82. Lallemand Probiotics for Infants and Women Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 83. Lallemand Probiotics for Infants and Women Product
Table 84. Lallemand Recent Development
Table 85. BioGaia Company Information
Table 86. BioGaia Description and Business Overview
Table 87. BioGaia Probiotics for Infants and Women Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 88. BioGaia Probiotics for Infants and Women Product
Table 89. BioGaia Recent Development
Table 90. Probi Company Information
Table 91. Probi Description and Business Overview
Table 92. Probi Probiotics for Infants and Women Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 93. Probi Probiotics for Infants and Women Product
Table 94. Probi Recent Development
Table 95. Biosearch Life Company Information
Table 96. Biosearch Life Description and Business Overview
Table 97. Biosearch Life Probiotics for Infants and Women Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 98. Biosearch Life Probiotics for Infants and Women Product
Table 99. Biosearch Life Recent Development
Table 100. Morinaga Milk Industry Company Information
Table 101. Morinaga Milk Industry Description and Business Overview
Table 102. Morinaga Milk Industry Probiotics for Infants and Women Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 103. Morinaga Milk Industry Probiotics for Infants and Women Product
Table 104. Morinaga Milk Industry Recent Development
Table 105. Synbio Tech Company Information
Table 106. Synbio Tech Description and Business Overview
Table 107. Synbio Tech Probiotics for Infants and Women Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 108. Synbio Tech Probiotics for Infants and Women Product
Table 109. Synbio Tech Recent Development
Table 110. Kerry Group Company Information
Table 111. Kerry Group Description and Business Overview
Table 112. Kerry Group Probiotics for Infants and Women Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 113. Kerry Group Probiotics for Infants and Women Product
Table 114. Kerry Group Recent Development
Table 115. Nestle Company Information
Table 116. Nestle Description and Business Overview
Table 117. Nestle Probiotics for Infants and Women Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 118. Nestle Probiotics for Infants and Women Product
Table 119. Nestle Recent Development
Table 120. Yakult Company Information
Table 121. Yakult Description and Business Overview
Table 122. Yakult Probiotics for Infants and Women Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 123. Yakult Probiotics for Infants and Women Product
Table 124. Yakult Recent Development
Table 125. Sabinsa Company Information
Table 126. Sabinsa Description and Business Overview
Table 127. Sabinsa Probiotics for Infants and Women Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 128. Sabinsa Probiotics for Infants and Women Product
Table 129. Sabinsa Recent Development
Table 130. Evivo Company Information
Table 131. Evivo Description and Business Overview
Table 132. Evivo Probiotics for Infants and Women Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 133. Evivo Probiotics for Infants and Women Product
Table 134. Evivo Recent Development
Table 135. AB-Biotics Company Information
Table 136. AB-Biotics Description and Business Overview
Table 137. AB-Biotics Probiotics for Infants and Women Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 138. AB-Biotics Probiotics for Infants and Women Product
Table 139. AB-Biotics Recent Development
Table 140. Bioflag Group Company Information
Table 141. Bioflag Group Description and Business Overview
Table 142. Bioflag Group Probiotics for Infants and Women Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 143. Bioflag Group Probiotics for Infants and Women Product
Table 144. Bioflag Group Recent Development
Table 145. Beijing Scitop Bio-tech Company Information
Table 146. Beijing Scitop Bio-tech Description and Business Overview
Table 147. Beijing Scitop Bio-tech Probiotics for Infants and Women Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 148. Beijing Scitop Bio-tech Probiotics for Infants and Women Product
Table 149. Beijing Scitop Bio-tech Recent Development
Table 150. Hebei Yiran Biological Technology Company Information
Table 151. Hebei Yiran Biological Technology Description and Business Overview
Table 152. Hebei Yiran Biological Technology Probiotics for Infants and Women Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 153. Hebei Yiran Biological Technology Probiotics for Infants and Women Product
Table 154. Hebei Yiran Biological Technology Recent Development
Table 155. Production Base and Market Concentration Rate of Raw Material
Table 156. Key Suppliers of Raw Materials
Table 157. Probiotics for Infants and Women Distributors List
Table 158. Probiotics for Infants and Women Customers List
Table 159. Probiotics for Infants and Women Market Trends
Table 160. Probiotics for Infants and Women Market Drivers
Table 161. Probiotics for Infants and Women Market Challenges
Table 162. Probiotics for Infants and Women Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Probiotics for Infants and Women Product Picture
Figure 2. Global Probiotics for Infants and Women Sales (US$ Million) by Type (2020 & 2024 & 2031)
Figure 3. Global Probiotics for Infants and Women Sales Market Share by Type in 2024 & 2031
Figure 4. Lactobacillus Product Picture
Figure 5. Bifidobacterium Product Picture
Figure 6. Others Product Picture
Figure 7. Global Probiotics for Infants and Women Sales (US$ Million) by Application (2020 & 2024 & 2031)
Figure 8. Global Probiotics for Infants and Women Sales Market Share by Application in 2024 & 2031
Figure 9. Infant Examples
Figure 10. Women Examples
Figure 11. Global Probiotics for Infants and Women Sales, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Probiotics for Infants and Women Sales Growth Rate (2020-2031) & (US$ Million)
Figure 13. Global Probiotics for Infants and Women Sales (Tons) Growth Rate (2020-2031)
Figure 14. Global Probiotics for Infants and Women Price Trends Growth Rate (2020-2031) & (US$/kg)
Figure 15. Probiotics for Infants and Women Report Years Considered
Figure 16. Global Market Probiotics for Infants and Women Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Figure 17. Global Probiotics for Infants and Women Revenue Market Share by Region: 2020 VS 2024
Figure 18. North America Probiotics for Infants and Women Revenue (US$ Million) Growth Rate (2020-2031)
Figure 19. North America Probiotics for Infants and Women Sales (Tons) Growth Rate (2020-2031)
Figure 20. Europe Probiotics for Infants and Women Revenue (US$ Million) Growth Rate (2020-2031)
Figure 21. Europe Probiotics for Infants and Women Sales (Tons) Growth Rate (2020-2031)
Figure 22. China Probiotics for Infants and Women Revenue (US$ Million) Growth Rate (2020-2031)
Figure 23. China Probiotics for Infants and Women Sales (Tons) Growth Rate (2020-2031)
Figure 24. Japan Probiotics for Infants and Women Revenue (US$ Million) Growth Rate (2020-2031)
Figure 25. Japan Probiotics for Infants and Women Sales (Tons) Growth Rate (2020-2031)
Figure 26. Global Probiotics for Infants and Women Revenue Share by Type (2020-2025)
Figure 27. Global Probiotics for Infants and Women Sales Share by Type (2026-2031)
Figure 28. Global Probiotics for Infants and Women Revenue Share by Type (2026-2031)
Figure 29. Global Probiotics for Infants and Women Revenue Share by Application (2020-2025)
Figure 30. Global Probiotics for Infants and Women Revenue Growth Rate by Application in 2020 & 2024
Figure 31. Global Probiotics for Infants and Women Sales Share by Application (2026-2031)
Figure 32. Global Probiotics for Infants and Women Revenue Share by Application (2026-2031)
Figure 33. Global Probiotics for Infants and Women Sales Share by Company (2024)
Figure 34. Global Probiotics for Infants and Women Revenue Share by Company (2024)
Figure 35. Global 5 Largest Probiotics for Infants and Women Players Market Share by Revenue in Probiotics for Infants and Women: 2020 & 2024
Figure 36. Probiotics for Infants and Women Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 37. Manufacturing Cost Structure of Probiotics for Infants and Women
Figure 38. Manufacturing Process Analysis of Probiotics for Infants and Women
Figure 39. Probiotics for Infants and Women Industrial Chain
Figure 40. Channels of Distribution (Direct Vs Distribution)
Figure 41. Distributors Profiles
Figure 42. Bottom-up and Top-down Approaches for This Report
Figure 43. Data Triangulation
Figure 44. Key Executives Interviewed
